A definite case of (L)-carbocisteine-induced pneumonia with CATCH22 syndrome

Intern Med. 2013;52(1):97-100. doi: 10.2169/internalmedicine.52.7882. Epub 2013 Jan 1.

Abstract

A 32-year-old male with CATCH22 syndrome presented with a high fever and productive cough after taking drugs for acute bronchitis, including (L)-carbocisteine. Chest radiography revealed ground-glass opacities in the bilateral lung fields. He had a history of similar pneumonia. Under the assumption of drug-induced pneumonia, or bacterial or viral pneumonia, all drugs including (L)-carbocisteine were discontinued, and antibiotics were started. A drug-induced lymphocyte stimulation test was positive only for (L)-carbocisteine. The only drug in common between this and the previous episode of pneumonia was (L)-carbocisteine. We thus concluded that this was a definite case of (L)-carbocisteine-induced pneumonia in a patient with CATCH22 syndrome.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / adverse effects*
  • Anti-Infective Agents / therapeutic use
  • Carbocysteine / adverse effects*
  • Carbocysteine / therapeutic use
  • Cough / drug therapy
  • Cough / physiopathology
  • DiGeorge Syndrome / complications*
  • DiGeorge Syndrome / diagnosis
  • Drug Hypersensitivity / etiology*
  • Drug Hypersensitivity / physiopathology
  • Follow-Up Studies
  • Humans
  • Male
  • Pneumonia / chemically induced*
  • Pneumonia / complications
  • Pneumonia / drug therapy*
  • Radiography, Thoracic / methods
  • Risk Assessment
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Carbocysteine